Cercar
01/01/2023
Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney
Boissier R., Rodriguez-Faba O., Zakri R.H., Hevia V., Budde K., Figueiredo A., García E.L., Olsburgh J., Regele H., Yuan C.Y., Breda A.. Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney. European Urology Focus. 2023; 9(3)DOI:10.1016/j.euf.2022.11.019. PMID:36567234. IF:4.900(Q1/2D).
01/01/2023
Reply by Authors
Tyson M.D., Morris D., Palou J., Rodriguez O., Mir M.C., Dickstein R.J., Guerrero-Ramos F., Scarpato K.R., Hafron J.M., Messing E.M., Cutie C.J., Maffeo J.C., Raybold B., Chau A., Stromberg K.A., Keegan K.A.. Reply by Authors. JOURNAL OF UROLOGY. 2023; 209(5)DOI:10.1097/JU.0000000000003195.02. PMID:37026638. IF:6.400(Q1/1D).
01/01/2023
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients with Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
Tyson M.D., Morris D., Palou J., Rodriguez O., Mir M.C., Dickstein R.J., Guerrero-Ramos F., Scarpato K.R., Hafron J.M., Messing E.M., Cutie C.J., Maffeo J.C., Raybold B., Chau A., Stromberg K.A., Keegan K.A.. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients with Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study. JOURNAL OF UROLOGY. 2023; 209(5)DOI:10.1097/JU.0000000000003195. PMID:37026631. IF:6.400(Q1/1D).
01/01/2023
Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: indications, timing and postoperative outcomes
Prudhomme T., Boissier R., Hevia V., Campi R., Pecoraro A., Breda A., Territo A.. Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: indications, timing and postoperative outcomes. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.04972-2. PMID:36094388. IF:4.900(Q1/2D).